Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Table S3 from UBA2-High Osteosarcoma Suppresses Immune Infiltration by Autophagy-Mediated MHC-I Degradation
  1. Home
  2. Publications
  3. Table S3 from UBA2-High Osteosarcoma Suppresses Immune Infiltration by Autophagy-Mediated MHC-I Degradation

Table S3 from UBA2-High Osteosarcoma Suppresses Immune Infiltration by Autophagy-Mediated MHC-I Degradation

Authors:
  • LYLingfeng Yu
    Lingfeng Yu
  • MLMengpan Li
    Mengpan Li
  • TLTongtong Liu
    Tongtong Liu
  • JWJiangpeng Wu
    Jiangpeng Wu
  • HMHuanliang Meng
    Huanliang Meng
  • WXWenyuan Xu
    Wenyuan Xu
  • WZWeisong Zhao
    Weisong Zhao
  • Hao Zhu
    Hao Zhu
  • ZWZhen Wang
    Zhen Wang
  • SGShibing Guo
    Shibing Guo
  • ZWZhuoying Wang
    Zhuoying Wang
  • Mengxiong Sun
    Mengxiong Sun

Open Access
Publisher website
Google Scholar
  • 2 July 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2326-6066.32872526
Abstract
Supplementary Table S3. Omics cohort.
Keywords
  • IMMUNOTHERAPY
  • COMBINATION IMMUNOTHERAPY
  • ONCOGENES & TUMOR SUPPRESSORS
  • ONCOGENES
  • SARCOMAS
  • OSTEOSARCOMA
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.